relative to the terminal patients' right to try act.

HB 701 allows terminally ill patients in New Hampshire to access experimental medical treatments that have not yet received full FDA approval. The bill directly affects patients with terminal illnesses who have exhausted all approved treatment options and seek unapproved drugs or devices through clinical trials or compassionate use programs. Key provisions remove state-level barriers to accessing these treatments by requiring healthcare providers to offer information about experimental options and limiting liability for providers who facilitate such access. The law takes effect January 1, 2026, after being signed by Governor Ayotte on August 20, 2025.